Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

Metabolic Explorer

Start price
Target price
Perf. (%)
€4.50
22.06.21
€3.00
-
17:43

Could be worthwhile Investment >10% per year
Orphazyme A/S

Start price
Target price
Perf. (%)
€6.30
21.06.21
-
21.06.22
9.52%
16:47

EBIT growth >5% per year expected
Capable Management
Few uniques
Dependend from some customers or products
AMC Entertainment Holdings Inc.

Start price
Target price
Perf. (%)
€46.80
22.06.21
-
17.06.22
4.83%
16:46

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
High valuation
buy
CorEnergy Infrastructure Trust Inc

Start price
Target price
Perf. (%)
€35.14
03.05.19
€36.08
04.11.21
-84.43%
20:46

buy
Cidara Therapeutics Inc

Start price
Target price
Perf. (%)
€2.41
31.03.19
€2.71
04.11.21
-31.57%
20:44

buy
Assembly Biosciences Inc.

Start price
Target price
Perf. (%)
€17.53
02.04.19
€23.45
04.11.21
-81.06%
20:43

buy
Nii Holdings Inc

Start price
Target price
Perf. (%)
€1.80
03.04.19
€2.71
04.11.21
-3.13%
20:43

buy
Software AG

Start price
Target price
Perf. (%)
€40.00
23.09.18
€43.50
04.11.21
-4.45%
20:41

CropEnergies AG

Start price
Target price
Perf. (%)
€11.58
19.06.21
€9.00
30.12.21
-3.28%
20:39

Could be worthwhile Investment >10% per year
buy
Metabolic Explorer

Start price
Target price
Perf. (%)
€2.79
25.01.21
€3.10
25.01.22
80.29%
20:36

Could be worthwhile Investment >10% per year
buy
Marathon Digital Holdings

Start price
Target price
Perf. (%)
€16.55
19.05.21
-
19.05.22
26.86%
16:08

Risky Investment
buy
Riot Blockchain Inc.

Start price
Target price
Perf. (%)
€19.02
19.05.21
-
19.05.22
25.45%
16:08

Risky Investment
AMC Entertainment Holdings Inc.

Start price
Target price
Perf. (%)
€54.06
02.06.21
-
02.06.22
-17.39%
16:08

Could be very worthwhile Investment >20% year
Curevac N.V.

Start price
Target price
Perf. (%)
€49.88
21.06.21
-
17.06.22
2.00%
09:55

Could be worthwhile Investment >10% per year
Fair valuation
EBIT growth >5% per year expected
Revenue growth >5% per year expected
buy
AMC Entertainment Holdings Inc.

Start price
Target price
Perf. (%)
€51.06
17.06.21
-
17.06.22
-8.34%
09:55

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
High valuation
buy
Bayer AG

Start price
Target price
Perf. (%)
€48.85
19.12.20
€62.00
22.06.21
7.59%
02:15

Fair valuation
Known brand
Increased challenges to pay loans and raise capital
Low dividend yield expected
buy
TAG Immobilien AG

Start price
Target price
Perf. (%)
€21.90
22.03.19
€29.00
04.11.21
24.93%
19:47

Could be worthwhile Investment >10% per year
buy
Moderna Inc.

Start price
Target price
Perf. (%)
€52.10
03.06.20
€200.00
04.11.21
238.39%
19:45

Bitcoin Group SE

Start price
Target price
Perf. (%)
€42.00
16.05.21
-
16.05.22
-4.88%
19:42

overvalued
Risky Investment
High risks in the balance sheet
Gamestop Corp.

Start price
Target price
Perf. (%)
€199.25
12.06.21
-
12.06.22
-15.71%
19:42

Risky Investment
overvalued
Outdated or very high risk business model
High risks in the balance sheet
buy
Curevac N.V.

Start price
Target price
Perf. (%)
€48.56
17.06.21
-
17.06.22
2.73%
16:09

Could be worthwhile Investment >10% per year
Fair valuation
EBIT growth >5% per year expected
Revenue growth >5% per year expected
Vicat S.A.

Start price
Target price
Perf. (%)
€41.10
14:46
€39.00
-
15:31

Could be worthwhile Investment >10% per year
buy
Orphazyme A/S

Start price
Target price
Perf. (%)
€6.55
11:56
-
21.06.22
-3.82%
15:21

EBIT growth >5% per year expected
Capable Management
Few uniques
Dependend from some customers or products
Stericycle Inc.

Start price
Target price
Perf. (%)
€57.18
07.02.21
-
07.02.22
5.35%
14:00

Probably not worthwhile Investment
Low dividend yield expected
buy
Infineon Technologies AG

Start price
Target price
Perf. (%)
€34.11
11.06.21
-
11.06.22
-4.81%
12:07

Could be very worthwhile Investment >20% year
Fair valuation
Leading role in innovation
Very small cyclical dependencies